TAT-Mediated Transduction of MafA Protein In Utero Results in Enhanced Pancreatic Insulin Expression and Changes in Islet Morphology

Alongside Pdx1 and Beta2/NeuroD, the transcription factor MafA has been shown to be instrumental in the maintenance of the beta cell phenotype. Indeed, a combination of MafA, Pdx1 and Ngn3 (an upstream regulator of Beta2/NeuroD) was recently reported to lead to the effective reprogramming of acinar cells into insulin-producing beta cells. These experiments set the stage for the development of new strategies to address the impairment of glycemic control in diabetic patients. However, the clinical applicability of reprogramming in this context is deemed to be poor due to the need to use viral vehicles for the delivery of the above factors. Here we describe a recombinant transducible version of the MafA protein (TAT-MafA) that penetrates across cell membranes with an efficiency of 100% and binds to the insulin promoter in vitro. When injected in utero into living mouse embryos, TAT-MafA significantly up-regulates target genes and induces enhanced insulin production as well as cytoarchitectural changes consistent with faster islet maturation. As the latest addition to our armamentarium of transducible proteins (which already includes Pdx1 and Ngn3), the purification and characterization of a functional TAT-MafA protein opens the door to prospective therapeutic uses that circumvent the use of viral delivery. To our knowledge, this is also the first report on the use of protein transduction in utero.

[1]  E. Kelly,et al.  Early intrauterine transfusion in severe red blood cell alloimmunization , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[2]  Ronald T. Wakai,et al.  Fetal cardiac arrhythmia detection and in utero therapy , 2010, Nature Reviews Cardiology.

[3]  P. Meda,et al.  Beta cell coupling and connexin expression change during the functional maturation of rat pancreatic islets , 2010, Diabetologia.

[4]  Nathan L. Vanderford,et al.  Phosphorylation within the MafA N Terminus Regulates C-terminal Dimerization and DNA Binding* , 2010, The Journal of Biological Chemistry.

[5]  Chia-Ming Chang,et al.  MafA promotes the reprogramming of placenta-derived multipotent stem cells into pancreatic islets-like and insulin+ cells , 2010, Journal of cellular and molecular medicine.

[6]  S. Bonner-Weir,et al.  Expression of MafA in pancreatic progenitors is detrimental for pancreatic development. , 2009, Developmental biology.

[7]  Nathan L. Vanderford,et al.  The Stability and Transactivation Potential of the Mammalian MafA Transcription Factor Are Regulated by Serine 65 Phosphorylation* , 2009, Journal of Biological Chemistry.

[8]  Douglas A. Melton,et al.  In vivo reprogramming of adult pancreatic exocrine cells to β-cells , 2008, Nature.

[9]  Claudio Punzo,et al.  Ultrasound-guided in utero injections allow studies of the development and function of the eye , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[10]  S. Bonner-Weir,et al.  Preferential reduction of beta cells derived from Pax6-MafB pathway in MafB deficient mice. , 2008, Developmental biology.

[11]  C. Ricordi,et al.  Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation , 2008, Diabetologia.

[12]  K. Kataoka,et al.  Roles and Regulation of Transcription Factor MafA in Islet β-cells , 2007 .

[13]  H. Kaneto,et al.  Role of PDX-1 and MafA as a potential therapeutic target for diabetes. , 2007, Diabetes research and clinical practice.

[14]  I. Artner,et al.  MafB is required for islet β cell maturation , 2007, Proceedings of the National Academy of Sciences.

[15]  K. Kataoka,et al.  MAFA controls genes implicated in insulin biosynthesis and secretion , 2007, Diabetologia.

[16]  K. Docherty,et al.  Comparative Analysis of Insulin Gene Promoters , 2006, Diabetes.

[17]  S. Bonner-Weir,et al.  A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. , 2006, Developmental biology.

[18]  A. Boschero,et al.  Histomorphology and ultrastructure of pancreatic islet tissue during in vivo maturation of rat pancreas. , 2006, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[19]  B. Fehse,et al.  Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. , 2006, Human gene therapy.

[20]  C. Ricordi,et al.  Protein Transduction: A Novel Approach to Induce In Vitro Pancreatic Differentiation , 2006, Cell transplantation.

[21]  Louette R. Johnson Lutjens.  Research , 2006 .

[22]  S. Oh,et al.  Cellular manipulation of human embryonic stem cells by TAT-PDX1 protein transduction. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  J. D. Engel,et al.  MafA Is a Key Regulator of Glucose-Stimulated Insulin Secretion , 2005, Molecular and Cellular Biology.

[24]  F. Barbé-Tuana,et al.  Delivery of TAT/PTD-Fused Proteins/Peptides to Islets via Pancreatic Duct , 2005, Cell transplantation.

[25]  H. Kaneto,et al.  A Crucial Role of MafA as a Novel Therapeutic Target for Diabetes*♦ , 2005, Journal of Biological Chemistry.

[26]  T. Matsuoka,et al.  The Islet β Cell-enriched MafA Activator Is a Key Regulator of Insulin Gene Transcription* , 2005, Journal of Biological Chemistry.

[27]  C. Ricordi,et al.  TAT-mediated neurogenin 3 protein transduction stimulates pancreatic endocrine differentiation in vitro. , 2005, Diabetes.

[28]  Steven F Dowdy,et al.  Cationic TAT peptide transduction domain enters cells by macropinocytosis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[29]  A. Boschero,et al.  Upregulation of the expression of tight and adherens junction-associated proteins during maturation of neonatal pancreatic islets in vitro , 2004, Journal of Molecular Histology.

[30]  C. Ricordi,et al.  Delivery of Bcl-XL or its BH4 domain by protein transduction inhibits apoptosis in human islets. , 2004, Biochemical and biophysical research communications.

[31]  C. Ricordi,et al.  PROTECTION OF ISLETS IN CULTURE BY DELIVERY OF OXYGEN BINDING NEUROGLOBIN VIA PROTEIN TRANSDUCTION , 2004, Transplantation proceedings.

[32]  C. Ricordi,et al.  DELIVERY OF PROTEINS AND PEPTIDES INTO LIVE CELLS BY MEANS OF PROTEIN TRANSDUCTION DOMAINS: POTENTIAL APPLICATION TO ORGAN AND CELL TRANSPLANTATION , 2004, Transplantation.

[33]  T. Matsuoka,et al.  Members of the Large Maf Transcription Family Regulate Insulin Gene Transcription in Islet β Cells , 2003, Molecular and Cellular Biology.

[34]  W. Shen,et al.  Quantitative comparison of membrane transduction and endocytosis of oligopeptides. , 2003, Biochemical and biophysical research communications.

[35]  C. Ricordi,et al.  Heme oxygenase-1 fused to a TAT peptide transduces and protects pancreatic β-cells , 2003 .

[36]  S. Dowdy,et al.  Modulation of cellular function by TAT mediated transduction of full length proteins. , 2003, Current protein & peptide science.

[37]  P. Robbins,et al.  Protection of Islets by in SituPeptide-mediated Transduction of the IκB Kinase Inhibitor Nemo-binding Domain Peptide* , 2003, The Journal of Biological Chemistry.

[38]  C. Ricordi,et al.  Proteins linked to a protein transduction domain efficiently transduce pancreatic islets. , 2001, Diabetes.

[39]  A. Eychène,et al.  Phosphorylation of MafA Is Essential for Its Transcriptional and Biological Properties , 2001, Molecular and Cellular Biology.

[40]  K. Zaret,et al.  A bipotential precursor population for pancreas and liver within the embryonic endoderm. , 2001, Development.

[41]  M. Giacca,et al.  Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans* , 2001, The Journal of Biological Chemistry.

[42]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[43]  M. Tsai,et al.  Regulation of the Pancreatic Islet-Specific GeneBETA2 (neuroD) by Neurogenin 3 , 2000, Molecular and Cellular Biology.

[44]  S. Kochanek,et al.  Frequency and Stability of Chromosomal Integration of Adenovirus Vectors , 1999, Journal of Virology.

[45]  Daniel H Turnbull,et al.  Alteration of limb and brain patterning in early mouse embryos by ultrasound-guided injection of Shh-expressing cells , 1998, Mechanisms of Development.

[46]  H. Ogino,et al.  Induction of lens differentiation by activation of a bZIP transcription factor, L-Maf. , 1998, Science.

[47]  N. Andrews,et al.  The Maf transcription factors: regulators of differentiation. , 1997, Trends in biochemical sciences.

[48]  M. Tsai,et al.  Cell-specific and ubiquitous factors are responsible for the enhancer activity of the rat insulin II gene. , 1991, The Journal of biological chemistry.

[49]  K. Kataoka,et al.  v-maf, a viral oncogene that encodes a "leucine zipper" motif. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Selbing,et al.  Preparation of packed red cells suitable for intravascular transfusion in utero , 1989, Transfusion.

[51]  Philip Rhodes,et al.  In Utero , 1971, Definitions.

[52]  T. Hirvikoski,et al.  Long-term outcome of prenatal treatment of congenital adrenal hyperplasia. , 2008, Endocrine development.

[53]  K. Kataoka,et al.  Roles and regulation of transcription factor MafA in islet beta-cells. , 2007, Endocrine journal.